ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,118.86
-0.12%
Gold vs US Dollar
2,326.73
-0.05%
Brent Oil
84.85
-0.66%
Bitcoin
60,291.60
-2.14%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Sciele Pharma (MM) (SCRX)

  7. Sciele Pharma (MM) (SCRX) News

Sciele Pharma (MM) (SCRX)

Sciele Pharma (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SCRX
DateTimeSourceHeadlineSymbolCompany
25/08/202118:00Business WiretheScore Bet Becomes Official Gaming Partner of Golf Canada and its Marquee Golf Championships, the RBC Canadian Open and CP Women’s OpenNASDAQ:SCRXSciele Pharma (MM)
19/08/202115:00Business WiretheScore Selects Toronto’s Waterfront Innovation Centre as Site for New, Expansive HeadquartersNASDAQ:SCRXSciele Pharma (MM)
05/08/202112:01Business WirePenn National Gaming to Acquire Score Media and Gaming, Creating North America’s Leading Digital Sports Content, Gaming and Technology CompanyNASDAQ:SCRXSciele Pharma (MM)
13/07/202122:01Business WiretheScore Reports F2021 Q3 Financial ResultsNASDAQ:SCRXSciele Pharma (MM)
06/07/202112:30Business WiretheScore to Report Q3 F2021 Financial Results on Tuesday, July 13, 2021NASDAQ:SCRXSciele Pharma (MM)
22/06/202121:16Business WiretheScore Applauds Passage by the Senate of Historic Legislation to Legalize Single Event Sports Betting in CanadaNASDAQ:SCRXSciele Pharma (MM)
23/04/202100:41Business WiretheScore Issues Statement Following the Passing of Bill C-218 by the House of CommonsNASDAQ:SCRXSciele Pharma (MM)
13/04/202122:02Business WiretheScore Reports Record F2021 Q2 Financial ResultsNASDAQ:SCRXSciele Pharma (MM)
06/04/202112:45Business WiretheScore To Report Q2 F2021 Financial Results on Tuesday, April 13, 2021NASDAQ:SCRXSciele Pharma (MM)
30/03/202118:02Business WirePGA TOUR Announces theScore Bet as an Official Betting OperatorNASDAQ:SCRXSciele Pharma (MM)
29/03/202113:30Business WiretheScore Secures Market Access for Mobile Sports Betting in Illinois Through Agreement with Caesars EntertainmentNASDAQ:SCRXSciele Pharma (MM)
01/03/202116:04Business WiretheScore Announces Closing of US$186.3 Million Initial Public Offering in the United StatesNASDAQ:SCRXSciele Pharma (MM)
09/10/200822:01Business WireShionogi Completes Acquisition of ScieleNASDAQ:SCRXSciele Pharma (MM)
09/10/200816:10Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:SCRXSciele Pharma (MM)
09/10/200813:02Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:SCRXSciele Pharma (MM)
09/10/200812:30Business WireShionogi and Sciele Announce Completion of Subsequent Offering PeriodNASDAQ:SCRXSciele Pharma (MM)
06/10/200814:54Edgar (US Regulatory)Sciele Pharma, Inc. - Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:SCRXSciele Pharma (MM)
06/10/200811:30Business WireShionogi and Sciele Announce Successful Tender Offer and Commencement of Subsequent OfferingNASDAQ:SCRXSciele Pharma (MM)
06/10/200811:05Edgar (US Regulatory)Sciele Pharma, Inc. - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:SCRXSciele Pharma (MM)
01/10/200814:45Edgar (US Regulatory)Sciele Pharma, Inc. - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:SCRXSciele Pharma (MM)
26/09/200800:38PR Newswire (US)Standard & Poor's Announces Update to the U.S. Market Cap Guidelines and Changes to U.S. IndicesNASDAQ:SCRXSciele Pharma (MM)
19/09/200814:44Edgar (US Regulatory)Sciele Pharma, Inc. - Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:SCRXSciele Pharma (MM)
19/09/200811:08Edgar (US Regulatory)Sciele Pharma, Inc. - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:SCRXSciele Pharma (MM)
19/09/200811:00Business WireShionogi and Sciele Announce Receipt of United States Antitrust ClearanceNASDAQ:SCRXSciele Pharma (MM)
16/09/200814:46Business WireSciele Completes Pivotal Phase III Program for Glycopyrrolate in Pediatric Patients with Chronic, Moderate-to-Severe DroolingNASDAQ:SCRXSciele Pharma (MM)
08/09/200816:19Edgar (US Regulatory)Sciele Pharma, Inc. - Statement of Ownership: Solicitation (SC 14D9)NASDAQ:SCRXSciele Pharma (MM)
08/09/200816:03Edgar (US Regulatory)Sciele Pharma, Inc. - Tender offer statement by Third Party (SC TO-T)NASDAQ:SCRXSciele Pharma (MM)
03/09/200821:49Edgar (US Regulatory)Sciele Pharma, Inc. - Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:SCRXSciele Pharma (MM)
03/09/200821:47Edgar (US Regulatory)Sciele Pharma, Inc. - Current report filing (8-K)NASDAQ:SCRXSciele Pharma (MM)
02/09/200821:58Edgar (US Regulatory)Sciele Pharma, Inc. - Statement of Ownership: Solicitation (SC 14D9)NASDAQ:SCRXSciele Pharma (MM)
 Showing the most relevant articles for your search:NASDAQ:SCRX

Your Recent History

NASDAQ
TELA
TELA Bio
USOTC
ORMFF
Orford Mining (PK)
TG
AOF
ATOSS Software
COIN
BDTXXUST
Block Duelers [Solona]
USOTC
GBOOY
Grupo Financiero Banorte... (QX)
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved